Health · Cyprus

Remedica voluntarily recalls specific batches of Remethan anti-inflammatory medication

4 sourcesFirst reported 21 days agoUpdated 21 days ago

Story Compare

AI summary: catch up in 20 seconds

Remedica Limited is voluntarily recalling specific batches of the anti-inflammatory medication Remethan 100mg Extended Release Tablets due to stability study results outside predefined limits.
The recalled batches have expiration dates ranging from September 2026 to November 2030.
Patients are advised to check for the recalled batches and consult their healthcare providers for further guidance.
Stocks of batches 116856, 122934, and 127806 may still be available despite the recall.
The recall is a precautionary measure and aims to ensure patient safety.

Generated by AI from the 4 sources below · always verify with the originals

AI summary: catch up in 20 seconds

Summarising the coverage…

Generated by AI from the 4 sources below · always verify with the originals

The full picture

AI-synthesised from 4 sources · no editorial bias

Remedica Limited has initiated a voluntary recall of specific batches of its anti-inflammatory medication, Remethan 100mg extended-release tablets. This action is part of a precautionary measure linked to stability study results indicating that certain parameters exceeded predefined limits.

The recalled batches have expiration dates ranging from September 2026 to November 2030. The company has mentioned that it is likely some stock from batches 116856, 122934, and 127806 may still be available in the market. Patients in possession of these recalled medications are advised to consult their healthcare providers for further guidance on discontinuation and alternative treatment options.

The full picture

AI-synthesised from 4 sources · no editorial bias

Synthesis generating…

Remedica voluntarily recalls specific batches of Remethan anti-inflammatory medication

All coverage (4)

Comments · 0 (subscribers)